Detalhe da pesquisa
1.
Compassionate use of delamanid in adults and children for drug-resistant tuberculosis: 5-year update.
Eur Respir J
; 57(5)2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33243846
2.
Long-term safety and tolerability of delamanid-containing regimens in MDR- and XDR-TB patients in a specialised tuberculosis treatment center in Berlin, Germany.
Eur Respir J
; 2020 Jul 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32631834
3.
Compassionate use of delamanid in combination with bedaquiline for the treatment of multidrug-resistant tuberculosis.
Eur Respir J
; 53(1)2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30361253
4.
Developing biomarker assays to accelerate tuberculosis drug development: defining target product profiles.
Lancet Microbe
; 2024 May 09.
Artigo
Inglês
| MEDLINE | ID: mdl-38735303
5.
Final treatment outcomes of multidrug- and extensively drug-resistant tuberculosis patients in Latvia receiving delamanid-containing regimens.
Eur Respir J
; 50(5)2017 11.
Artigo
Inglês
| MEDLINE | ID: mdl-29122917
6.
Early outcomes in MDR-TB and XDR-TB patients treated with delamanid under compassionate use.
Eur Respir J
; 50(1)2017 07.
Artigo
Inglês
| MEDLINE | ID: mdl-28751415
7.
Point-of-Care COVID-19 Antigen Testing in Exposed German Healthcare Workers-A Cost Model.
Int J Environ Res Public Health
; 18(20)2021 10 14.
Artigo
Inglês
| MEDLINE | ID: mdl-34682514
8.
Long-term mortality assessment of multidrug-resistant tuberculosis patients treated with delamanid.
Eur Respir J
; 45(5): 1498-501, 2015 May.
Artigo
Inglês
| MEDLINE | ID: mdl-25700385
9.
A pooled analysis of the durability and predictors of treatment response of cilostazol in patients with intermittent claudication.
Vasc Med
; 15(3): 181-8, 2010 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-20385711
10.
Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial.
Lancet Respir Med
; 7(3): 249-259, 2019 03.
Artigo
Inglês
| MEDLINE | ID: mdl-30630778
11.
Cost effectiveness of treating multi-drug resistant tuberculosis by adding Deltyba™ to background regimens in Germany.
Respir Med
; 109(5): 632-41, 2015 May.
Artigo
Inglês
| MEDLINE | ID: mdl-25862597
12.
Cilostazol treatment of claudication in diabetic patients.
Curr Med Res Opin
; 18(8): 479-87, 2002.
Artigo
Inglês
| MEDLINE | ID: mdl-12564659
13.
Treating peripheral arterial disease in patients with diabetes.
Diabetes Obes Metab
; 4 Suppl 2: S26-31, 2002 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-12180355